Clear Street initiated coverage of Rapt Therapeutics with a Buy rating and set a $3 price target, as the research firm has ...

Test your allergy knowledge with a quiz to recognize symptoms, avoid triggers, and manage flare-ups effectively.

As spring blooms in May, weed pollen peaks—triggering allergies for millions. Explore the science behind this reaction and ...

Drugmakers are turning to biomarkers, like folate receptor alpha, and even cell therapies to tackle this deadly cancer in new ...

Discover the causes, symptoms, and treatment of food allergies, and learn how to manage them safely with expert tips on ...

At the intersection of a red meat allergy and a cancer-drug reaction investigations, researchers pinned a lone star culprit.

Learn about food allergies, food intolerance, types of food allergies, symptoms, and effective food allergy treatments to ...

Researchers at King’s are the first in the world to develop a treatment from a different type of antibody, called IgE. IgE has important roles in triggering the immune response during an allergic ...

Researchers at King's are the first in the world to develop a treatment from a different type of antibody, called IgE. IgE has important roles in triggering the immune response during an allergic ...

Epsilogen, the global leader in the development of immunoglobulin E (IgE) antibody therapeutics, announced that it has completed the acquisition of TigaTx, Inc, a biotechnology company developing ...

Both companies are focused on immunoglobulin antibodies, with Epsilogen’s work orienting around IgE, while TigaTX has been hard at work developing IgA therapies. The deal, for which Epsilogen is ...